Barclays
TMCI icon

Barclays’s Treace Medical Concepts TMCI Stock Holding History

Barclays’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$332K Buy
71,948
+20,318
+39% +$91.1K ﹤0.01% 3694
2026
Q2 		$205K Buy
51,630
+15,194
+42% +$41.8K ﹤0.01% 3681
2026
Q1 		$43.7K Sell
36,436
-51,228
-58% -$102K ﹤0.01% 4371
2025
Q4 		$215K Buy
87,664
+6,077
+7% +$26.4K ﹤0.01% 4272
2025
Q3 		$547K Sell
81,587
-18,704
-19% -$122K ﹤0.01% 3754
2025
Q2 		$590K Buy
100,291
+47,228
+89% +$308K ﹤0.01% 3665
2025
Q1 		$445K Sell
53,063
-24,222
-31% -$218K ﹤0.01% 3604
2024
Q4 		$539K Sell
77,285
-2,411
-3% -$16.1K ﹤0.01% 3773
2024
Q3 		$460K Buy
79,696
+62,073
+352% +$399K ﹤0.01% 3834
2024
Q2 		$117K Sell
17,623
-23,423
-57% -$189K ﹤0.01% 3834
2024
Q1 		$536K Sell
41,046
-30,246
-42% -$403K ﹤0.01% 3543
2023
Q4 		$918K Buy
71,292
+54,952
+336% +$555K ﹤0.01% 3496
2023
Q3 		$199K Sell
16,340
-2,934
-15% -$53.7K ﹤0.01% 3303
2023
Q2 		$475K Buy
19,274
+653
+4% +$16.9K ﹤0.01% 2781
2023
Q1 		$479K Buy
18,621
+9,666
+108% +$227K ﹤0.01% 3297
2022
Q4 		$210K Buy
8,955
+7,541
+533% +$174K ﹤0.01% 3811
2022
Q3 		$32K Sell
1,414
-3,654
-72% -$70.7K ﹤0.01% 3920
2022
Q2 		$73K Sell
5,068
-3,282
-39% -$55.3K ﹤0.01% 3902
2022
Q1 		$157K Buy
+8,350
New +$162K ﹤0.01% 3567

Other funds holding TMCI

Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
GA
Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return
Weber Capital Management
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LS
LCW Services Virginia Beach, Virginia $240M AUM 12.93% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Barclays's TMCI Position: Q3 2026 in Review

Barclays increased its Treace Medical Concepts (TMCI) stake by 39% in Q3 2026, buying an estimated $91.1K and bringing the position to 71,948 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #3694.

Barclays first reported a position in TMCI in Q1 2022 and has held it in 19 quarters since. The position peaked at $918K in Q4 2023. 42 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Barclays held 71,948 shares of Treace Medical Concepts worth $332K as of Q3 2026.
  • Barclays bought 20,318 Treace Medical Concepts shares in Q3 2026, an estimated $91.1K.
  • Treace Medical Concepts made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3694 holding.
  • Barclays first reported a position in Treace Medical Concepts in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Treace Medical Concepts position peaked at $918K in Q4 2023.
  • 42 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.